Nantahala Capital Management LLC 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:53 pm Sale | 2024-09-30 | 13G | Lyra Therapeutics, Inc. LYRA | Nantahala Capital Management LLC | 702,106 1.061% | -4,050,218 (-85.23%) | Filing |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Nantahala Capital Management LLC | 4,752,324 8.900% | 2,531,494 (+113.99%) | Filing |
| 2023-02-14 4:48 pm Purchase | 2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Nantahala Capital Management LLC | 2,220,830 7.000% | 2,220,830 (New Position) | Filing |